Aiforia
Helsinki, Uusimaa, Finland · Artificial Intelligence, Biotechnology, Consulting
Aiforia is a Helsinki-based life-science company providing deep learning AI solutions for pathology. Founded in 2013 as a spin-off from the University of Helsinki, it delivers software solutions that elevate diagnostic capabilities in image analysis. Aiforia equips pathologists and scientists with AI software for translating images into discoveries, decisions, and diagnoses. The company is publicl
Key facts
- Headquarters
- Helsinki, Uusimaa, Finland
- Employees
- 79
- Industries
- Artificial Intelligence, Biotechnology, Consulting
- Status
- Private
- Website
- www.aiforia.com
- Company page
Recent activity at Aiforia
- : Helsinki-based Aiforia secures €20 million EIB financing to advance AI-powered cancer diagnostics. This venture debt financing will accelerate Aiforia’s product development and enhance commercial operations.
- : Aiforia partners with Quorum Technologies to expand AI-powered image analysis solutions in Canada
- : Aiforia Technologies plc Appoints Panu Kauppila as Chief Product Officer and A Member of the Management Team
Aiforia funding history
| Date | Round | Amount |
|---|---|---|
| Aug 2026 | Debt Financing | $23.1M |
Leadership
- Gary Chisholm, Sales Director, Americas
- Darshan Kumar, Director (Global Field Application Science Team)
- Kaisa Helminen, Chief Operating Officer
- Panu Kauppila, Chief Product Officer
Verified email and direct lines for Aiforia’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Aiforia in the news
- Aiforia Technologies Oyj : Invitation to Aiforia's investor webinar on November 17, 2026 - www.marketscreener.com (Oct 28, 2026)
- Aiforia's partner Proscia acquired by Agilent - Inderes (Oct 13, 2026)
- Aiforia enters into an agreement with PathAI - Inderes (Oct 08, 2026)
- An injury-associated lobular microniche is associated with the classical tumor cell phenotype in pancreatic cancer - Nature (Sep 26, 2025)
- Aiforia H1'26: Still a long way to go before reaching profitability - Inderes (Aug 31, 2026)
- Aiforia update: Foothold in the US market strengthens through the PathAI partnership - Inderes (Oct 26, 2026)
Companies similar to Aiforia
- Nabla · Artificial Intelligence, Biotechnology, Machine Learning, Software
- Scarlet · Artificial Intelligence, Biotechnology, Machine Learning, Software
- RegASK · Artificial Intelligence, Biotechnology, Machine Learning, Software
- Odysight.ai · Artificial Intelligence, Biotechnology, Machine Learning, Software
- Pixeom · Artificial Intelligence, Biotechnology, Machine Learning, Software
About Aiforia: questions and answers
What does Aiforia do?
Aiforia is a Helsinki-based life-science company providing deep learning AI solutions for pathology. Founded in 2013 as a spin-off from the University of Helsinki, it delivers software solutions that elevate diagnostic capabilities in image analysis. Aiforia equips pathologists and scientists with AI software for translating images into discoveries, decisions, and diagnoses. The company is publicl
Where is Aiforia headquartered?
Aiforia is headquartered in Helsinki, Uusimaa, Finland.
How many employees does Aiforia have?
Aiforia has about 79 employees.
Has Aiforia raised funding?
Yes. Fundz has recorded 1 funding event for Aiforia. The most recent, Debt Financing of $23.1M, was in Aug 2026.
What is the latest news on Aiforia?
On Aug 03, 2026, Helsinki-based Aiforia secures €20 million EIB financing to advance AI-powered cancer diagnostics. This venture debt financing will accelerate Aiforia’s product development and enhance commercial operations.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy